Implants have become a boon for many as it replaces the actual organs in the body. Many implants have been developed to offer artificial vision.
Retinal Implants Clear Second Phase of Trials
Researchers reported that German-designed implants aimed at restoring vision to patients blinded by retinal disease have succeeded in the second phase of trials.
Researchers reported that German-designed implants aimed at restoring vision to patients blinded by retinal disease have succeeded in the second phase of trials.
‘Retinal Implant AG, a German firm, has obtained European regulatory approval for its Alpha AMS subretinal implant for people who have become blind due to retinitis pigmentosa.’
Retinitis pigmentosa is one of the most common inherited diseases of the retina. It causes night blindness in the early stages, along with atrophy and pigment changes in the retina, constriction of the visual field and eventual blindness. This new device offers an improved vision clarity featuring 1600 pixels, which is 100 more than the earlier one. The implanted chip acts as a retina and captures images multiple times a second. It also stimulates the optic fiber based on what is caught.
There are no external cameras in this device, which enables it to give a natural vision. It also helps the patient to see clearly around the eyes without even having to turn the entire head to change the point of view.
CRISPR Technique Offers Precise Blindness Therapy by Repairing Stem Cells
Correcting a blindness-causing gene mutation in patient-derived stem cells using CRISPR/cas9 technique may help in personalized therapies for retinal diseases.
Correcting a blindness-causing gene mutation in patient-derived stem cells using CRISPR/cas9 technique may help in personalized therapies for retinal diseases.
Source-Medindia
Researchers Identify How Photoreceptor Cells in Retinitis Pigmentosa Die
Boston (Aug. 20, 2012) – Research conducted at the Angiogenesis Laboratory at Massachusetts Eye and Ear Infirmary, has for the first time, identified the mode of death of cone photoreceptor
Boston (Aug. 20, 2012) – Research conducted at the Angiogenesis Laboratory at Massachusetts Eye and Ear Infirmary, has for the first time, identified the mode of death of cone photoreceptor
Two Experimental Treatments Found to Produce Long Term Improvement for Retinitis Pigmentosa
Two experimental treatments have been found to improve the visual function in mouse models of retinitis pigmentosa.
Two experimental treatments have been found to improve the visual function in mouse models of retinitis pigmentosa.
